Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders - Hutson, Peter H.; Tarazi, Frank I.; Madhoo, Manisha; Slawecki, Craig; Patkar, Ashwin A. (Pharmacology & therapeutics (Oxford), 2014)
Keywords: Amphetamine - pharmacology; Amphetamine - therapeutic use; Animals; Biogenic Amines - metabolism; Biological and medical sciences; Glutamic Acid - metabolism; Humans; Lens diseases; Medical sciences; Mental Disorders - drug therapy; Mental Disorders - metabolism; Ophthalmology; Opioid Peptides - metabolism; Receptor, Cannabinoid, CB1 - metabolism; Receptor, Cannabinoid, CB2 - metabolism; Synaptic Transmission - drug effects; Amphetamine derivatives; CNS stimulant; Psychotropic; Preclinical trial; Monoamine; Opiates; Pharmacology; Cannabinoid; Glutamate; Monoamines; Endogenous; Treatment; Amphetamine; Endocannabinoid; Excitatory aminoacid; Neurotransmitter; Mental disorder; Amfetamine; Endogenous opioids; Endocannabinoids